Publication | Closed Access

Subcutaneous alemtuzumab vs ATG in adjusted conditioning for allogeneic transplantation: influence of Campath dose on lymphoid recovery, mixed chimerism and survival

Transplant RejectionTransplantationCampath DoseImmunosuppressive TherapyImmunologyAutoimmunityMixed ChimerismGraft SurvivalBlood TransplantationImmunotherapyMedicineCell TransplantationGraft RejectionAdjusted Conditioning